drugset / Trial / NCT01407016

A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects

NCT01407016

Phase 1 Completed 6 enrolled Pfizer
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of metronidazole following single and multiple intravenous infusion in healthy Japanese adult subjects.

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg Intravenous

Indications